iProg progranulin therapy (Sinfonia Biotherapeutics)

N/A

Report date: 2025/01/26 15:39:28
NME

Base Information

Drug NameiProg progranulin therapy (Sinfonia Biotherapeutics)
Drug Alias Nameneurotrophic therapy (Sinfonia Biotherapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProgranulin modulators
TargetsProgranulin
Therapy Area/IndicationsFrontotemporal dysplasiaParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSinfonia Biotherapeutics AB
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsFrontotemporal dysplasiaParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A